脆性*三聯(lián)體抗體,Anti-FHIT抗體現(xiàn)貨產(chǎn)品、*.歡迎廣大客戶前來(lái)咨詢上海研盟生物科技有限公司客服了解更多有關(guān)本產(chǎn)品的信息!(科研用產(chǎn)品,非臨床及診斷)我公司將誠(chéng)竭為您服務(wù),期待您的來(lái)電。:、
中文名稱:脆性*三聯(lián)體抗體
英文名稱:Anti-FHIT抗體
產(chǎn)品編號(hào):BYK-1769R
英文別名:fragile histidine triad; AP3A hydrolase; AP3A hydrolase fragile site 3p14.2; AP3Aase; Bis 5' adenosyl triphosphatase; Dinucleosidetriphosphatase; FRA 3B; FRA3B; Fragile histidine triad gene; Fragile histidine triad protein; Tumor suppressor protein; G6PC_HUMAN.
產(chǎn)品規(guī)格:0.1ml、0.2ml、1ml
產(chǎn)品用途:科研實(shí)驗(yàn)
產(chǎn)品價(jià)格:請(qǐng)報(bào)價(jià)
說明書:請(qǐng)?zhí)砑涌头?直接索取
抗體來(lái)源:該指標(biāo)有兩種產(chǎn)品,一種是兔來(lái)源抗體,一種是鼠來(lái)源抗體
克隆類型:兔來(lái)源為多克隆抗體,鼠來(lái)源單克隆抗體
交叉反應(yīng):請(qǐng)索取說明書查看
性 狀:Lyophilized or Liquid
濃 度:1mg/1ml
亞 型:IgG
純化方法: affinity purified by Protein A
儲(chǔ) 存 液: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol
保存條件: Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
脆性*三聯(lián)體抗體,Anti-FHIT抗體產(chǎn)品介紹:Glucose-6-phosphatase (G6Pase) is a multi-subunit integral membrane protein of the endoplasmic reticulum that is composed of a catalytic subunit and transporters for G6P, inorganic phosphate, and glucose. This gene (G6PC) is one of the three glucose-6-phosphatase catalytic-subunit-encoding genes in human: G6PC, G6PC2 and G6PC3. Glucose-6-phosphatase catalyzes the hydrolysis of D-glucose 6-phosphate to D-glucose and orthophosphate and is a key enzyme in glucose homeostasis, functioning in gluconeogenesis and glycogenolysis. Mutations in this gene cause glycogen storage disease type I (GSD1). This disease, also known as von Gierke disease, is a metabolic disorder characterized by severe hypoglycemia associated with the accumulation of glycogen and fat in the liver and kidneys.
初次體液免疫是指宿主*次接觸外來(lái)TD抗原后血清中逐漸出現(xiàn)抗原特異性抗體的過程。初次體液免疫應(yīng)答的延遲相(從抗原免疫到抗體水平達(dá)到高峰的時(shí)間)為6-10天,起初幾天血清中的抗原特異性抗體主要為親和力較低的IgM,后期以IgG為主。初次應(yīng)答過程的血清中抗原特異性抗體的高峰濃度較低且維持時(shí)間較短。再次體液免疫應(yīng)答是指曾被某抗原免疫過的宿主再次接觸該抗原時(shí)血清中迅速出現(xiàn)抗原特異性抗體的過程,其延遲相僅為4-5天,血清抗體以IgG為主,其高峰濃度較高且維持時(shí)間較長(zhǎng)。再次應(yīng)答所產(chǎn)生的抗體還有親和力成熟現(xiàn)象,即該抗體與抗原的親和力明顯高于初次應(yīng)答產(chǎn)生的抗體。(上海研盟生物科技有限公司)
免疫應(yīng)答過程:
1.抗原進(jìn)入機(jī)體;
2.抗原刺激 B淋巴細(xì)胞,使之分化增殖成為抗體分泌漿細(xì)胞和記憶細(xì)胞(初次免疫應(yīng)答);
3.抗體主要由漿細(xì)胞分泌 ;
4.記憶細(xì)胞再次受到特異性抗原刺激后會(huì)被激活而成為分泌抗體的漿細(xì)胞(再次免疫應(yīng)答);
5.記憶B細(xì)胞是長(zhǎng)命細(xì)胞,可以存活數(shù)月甚至機(jī)體終生 。
相關(guān)優(yōu)質(zhì)產(chǎn)品:
Stra8(Stimulated by retinoic acid gene 8) *激活基因8抗體
STRO-1 一種間充質(zhì)干細(xì)胞抗體
streptomycin *抗體
SULT1E1(Estrogen Sulfotranferase) 雌激素硫酸轉(zhuǎn)移酶抗體
Survivin 細(xì)胞凋亡抑制因子抗體
SUMO(small ubiquitin-related modifier) 類泛素蛋白抗體
SV2A(Synaptic vesicle protein 2A) 突觸泡蛋白2A抗體
SYPH1(Synphilin-1) synphilin-1抗體
phospho-Syndecan 4(pSer179) 磷酸化多配體聚糖4抗體
SYK(Spleen tyrosine kinase) 非受體型*蛋白激酶抗體
SYVN1(synovial apoptosis inhibitor 1) hu、 rat、 mo、 cattle 滑膜細(xì)胞凋亡抑制物1抗體
alpha-Synuclein(CT) 核突觸蛋白-α抗體(C端)
α-Synuclein 核突觸蛋白-α抗體
α-Synuclein 核突觸蛋白/突觸素-1抗體
gamma Synuclein/SNCG 核突觸蛋白-γ抗體
Syntaxin 1/Syn1A(Synaptotagmin-Associated 35kD Protein) 突觸融合蛋白1抗體
SYT3(Synaptotagmin 3) 突觸結(jié)合蛋白3抗體
T3(TRIIODOTYMROXINE) 三碘甲狀腺素T3抗體
T3(TriiodotYMroxine) 三碘甲狀腺素T3抗體
TACR3/NK-3 receptor(tacBYKinin receptor 3) 速激肽受體3抗體
Tanis/SELS(Selenoprotein S) 炎癥負(fù)調(diào)控因子蛋白抗體
TANK(TRAF-associated NF-κB kinase) TANK(TRAF-associated NF-κB kinase)
Tat(tyrosine aminotransferase) 細(xì)胞*轉(zhuǎn)氨酶抗體
Tau protein 微管相關(guān)蛋白抗體
TRH (TYMrotropin releasing hormone ) 促甲狀腺素釋放激素抗體
Tau protein 微管相關(guān)蛋白抗體